CloudMD Software & Services Inc. (DOCRF)
| Previous close | 0.0250 |
| Open | 0.0250 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0175 - 0.0250 |
| 52-week range | 0.0175 - 0.1430 |
| Volume | |
| Avg. volume | 54,125 |
| Market cap | 9.679M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
CloudMD Reports 2023 Results for the Full Year and Fourth Quarter
Full year 2023 revenue of $90.9 million compared to $99.4 million in 2022, and $90.5 million compared to $86.7 million on a normalized basis, excluding one-time COVID mandates.Q4 2023 gross profit margin1 of 39.7% was relatively flat compared to Q3 2023 and improved 380 bps from the prior year.Q4 2023 Adjusted EBITDA1 loss of $1.4 million compared to a gain of $0.6 million in the previous quarter, annual improvement of $7.2 million compared to prior year.Net loss from continuing operations of $6
- GlobeNewswire
CloudMD Announces Go-Private Transaction with CPS Capital
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, and CPS Capital (“CPS Capital”), an entrepreneurial investment firm partnering with businesses and teams to realize their growth goals, are pleased to announce that they have entered into an arrangement agreement (the “Arrangement Agreement”) pursuant to which CPS Capital (through an affiliate
- GlobeNewswire
CloudMD Announces Late Filing of Annual Financial Statements
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, announced today that it is unable to file its audited consolidated annual financial statements and accompanying management’s discussion and analysis for the fourth quarter and year ended December 31, 2023 (the “Annual Financial Filings”) by the filing deadline of April 29, 2024
